Switching to Once-Weekly Insulin: Blood Sugar Control and Satisfaction
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how well once-weekly insulin icodec controls blood sugar and improves quality of life for people with type 2 diabetes who currently take daily insulin injections. You'll switch from your daily insulin to a once-weekly injection and the study will track your blood sugar control, treatment satisfaction, and how well you stick with the new schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes diagnosed at least 1 year ago
- You currently take once- or twice-daily basal insulin (long-acting insulin) for at least 6 months
- You have NOT taken bolus insulin (rapid-acting insulin for meals) for the past 90 days or longer
- You have a recent blood sugar control test (HbA1c) from the past 90 days or at your first study visit
- You have never tried once-weekly insulin before
- You are 18 years old or older and able to understand and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether switching from daily basal insulin to once-weekly insulin icodec improves blood sugar control, treatment satisfaction, and how well people stick with the new insulin. It may be a good option if you have type 2 diabetes and are already using a daily basal insulin.
This study tests a new once-weekly insulin shot (icodec) compared to daily long-acting insulins for people with type 2 diabetes whose blood sugar is not well controlled on their current non-insulin medications.
This study compares two newer once-weekly injectable medicines to see which one works better for lowering blood sugar in people with type 2 diabetes. You may join if your blood sugar is not well controlled on your current diabetes pills.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
This study tests a new once-weekly insulin called Icodec for people with type 2 diabetes. It looks at the best way to start using it, including a possible extra dose on day 4, to help control blood sugar safely.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.